Biocon shares react as revised disclosure received for Mylan takeover
Why did Biocon Ltd shares fall today?
Biocon Ltd shares saw a slight decline today, with the stock falling by 0.06% to ₹417.15 as of 11:50 AM on Thursday. This minor drop came after the company received a revised disclosure from Mylan Inc., a U.S.-based pharmaceutical company, which was submitted to the stock exchanges to correct an earlier error in shareholding information. Mylan had previously reported selling a significant block of Biocon shares—specifically, 9,19,67,019 equity shares, representing about 5.64% of Biocon's total equity capital—back in July.
In their initial disclosure on July 15, 2026, Mylan mistakenly stated that they still held those shares after the sale, but this was a typographical error. Now, in a new disclosure dated August 26, 2026, Mylan has clarified that after selling those shares, their stake in Biocon Ltd. is actually nil, meaning they no longer own any part of the company. This rectification of paperwork doesn't introduce any new business changes but might have caused brief uncertainty among investors, leading to the small dip in share price as they digested the updated information.
What does Biocon Ltd do?
Biocon Limited is a company based in Electronic City, Bangalore, India. It is a publicly traded entity, with its equity shares listed on exchanges such as the National Stock Exchange of India and BSE Limited.
The company is subject to the Securities and Exchange Board of India's takeover regulations. It was involved in a transaction where another entity, Mylan Inc., disclosed the sale of a portion of its equity shares in Biocon Limited.
Biocon Ltd Financials
In CroresBiocon Ltd's revenue declined from ₹4484.3 Crores in March 2026 to ₹4291.8 Crores in June 2026, while its net profit grew from ₹125.9 Crores to ₹141.1 Crores over the same period. This indicates a quarter-on-quarter revenue contraction alongside an improvement in profitability.
Biocon Ltd Shareholding Pattern
Promoter holding stands at 9.36% of the total share capital. Foreign Institutional Investors (FIIs) hold 0.0% stake in the company, while Domestic Institutional Investors (DIIs) hold 0.0%. Public shareholders hold the remaining 90.65% stake in Biocon Ltd.
Biocon Ltd FAQs
Q: Why did Biocon shares fall 0.06% today?
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mylan Inc.. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Biocon Ltd?
As per the latest data, promoters hold 9.36% stake in Biocon Ltd, while FII holding stands at 0.0%. Domestic institutional investors hold 0.0%, and public shareholders account for 90.65% of the equity.
Q: What is the current stock price of Biocon Ltd?
Biocon Ltd shares are currently trading at ₹417.15, recording a decline of 0.06% from the previous close.
Q: What is the market capitalization of Biocon Ltd?
The company currently has a market capitalization of ₹67924.27 crore, reflecting its valuation in the Indian equity market.